Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centre.
| dc.contributor.author | Khoja, Leila | |
| dc.contributor.author | McGurk, Antony | |
| dc.contributor.author | O'Hara, Catherine | |
| dc.contributor.author | Chow, Shien | |
| dc.contributor.author | Hasan, Jurjees | |
| dc.date.accessioned | 2015-01-08T16:40:37Z | |
| dc.date.available | 2015-01-08T16:40:37Z | |
| dc.date.issued | 2015-01 | |
| dc.identifier.citation | Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centre. 2015, 51 (2):233-40 Eur J Cancer | en |
| dc.identifier.issn | 1879-0852 | |
| dc.identifier.pmid | 25500146 | |
| dc.identifier.doi | 10.1016/j.ejca.2014.11.011 | |
| dc.identifier.uri | http://hdl.handle.net/10541/337977 | |
| dc.description.abstract | The national confidential enquiry into patient outcomes and death (NCEPOD) set important benchmarks in assessing the quality of care received by patients dying within 30days of systemic anticancer therapy (SACT). Monthly morbidity and mortality audits conducted to recommendations in the NCEPOD were commenced at the Christie NHS Foundation Trust in 2009, specifically to assess and improve patient outcomes. | |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to European journal of cancer (Oxford, England : 1990) | en |
| dc.title | Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centre. | en |
| dc.type | Article | en |
| dc.contributor.department | The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UKThe Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK | en |
| dc.identifier.journal | European Journal of Cancer | en |
| html.description.abstract | The national confidential enquiry into patient outcomes and death (NCEPOD) set important benchmarks in assessing the quality of care received by patients dying within 30days of systemic anticancer therapy (SACT). Monthly morbidity and mortality audits conducted to recommendations in the NCEPOD were commenced at the Christie NHS Foundation Trust in 2009, specifically to assess and improve patient outcomes. |